首頁 > 市場調查報告書 > 製藥

神經疾病

失智症·阿茲海默症治療的全球市場 - 產業規模，佔有率，趨勢，機會，預測(2018年～2028年)各級藥品，各流通管道，各地區，預測，機會(2028年)

市場調查報告書

商品編碼

1174496

失智症·阿茲海默症治療的全球市場 - 產業規模，佔有率，趨勢，機會，預測(2018年～2028年)各級藥品，各流通管道，各地區，預測，機會(2028年)

Dementia and Alzheimer's Disease Treatment Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Drug Class, By Distribution Channel, By Region, Forecast & Opportunities, 2028

出版日期: 2022年12月01日 | 出版商:

TechSci Research | 英文 112 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球失智症·阿茲海默症治療市場在2024年～2028年的預測期間內將展現驚人成長。

阿爾茨海默病和癡呆症患病率的增加以及對這些疾病的認識不斷提高正在推動市場的增長。

本報告提供全球失智症·阿茲海默症治療市場相關調查分析，提供市場規模與預測，各地區預測，競爭情形等資訊。

市場規模與預測
市場佔有率與預測
- 各級藥品(膽鹼工作性/膽鹼酯酶(ChE)抑制劑(Donepezil，galantamine，Rivastigmine)，Memantine，並用藥(Memantine·Donepezil))
- 各流通管道(醫院藥局，零售藥局，線上藥局)
- 各企業(2022年)
- 各地區
市場魅力指數

第7章亞太地區的失智症·阿茲海默症治療市場預測

市場規模與預測
市場佔有率與預測
亞太地區:各國分析
- 中國的失智症·阿茲海默症治療市場預測
- 印度的失智症·阿茲海默症治療市場預測
- 澳洲的失智症·阿茲海默症治療市場預測
- 日本的失智症·阿茲海默症治療市場預測
- 韓國的失智症·阿茲海默症治療市場預測

第8章歐洲的失智症·阿茲海默症治療市場預測

市場規模與預測
市場佔有率與預測
歐洲:各國分析
- 法國的失智症·阿茲海默症治療市場預測
- 德國的失智症·阿茲海默症治療市場預測
- 英國的失智症·阿茲海默症治療市場預測
- 義大利的失智症·阿茲海默症治療市場預測
- 西班牙的失智症·阿茲海默症治療市場預測

第9章北美的失智症·阿茲海默症治療市場預測

市場規模與預測
市場佔有率與預測
北美:各國分析
- 美國的失智症·阿茲海默症治療市場預測
- 墨西哥的失智症·阿茲海默症治療市場預測
- 加拿大幅失智症·阿茲海默症治療市場預測

第10章南美的失智症·阿茲海默症治療市場預測

市場規模與預測
市場佔有率與預測
南美:各國分析
- 巴西的失智症·阿茲海默症治療市場預測
- 阿根廷的失智症·阿茲海默症治療市場預測
- 哥倫比亞的失智症·阿茲海默症治療市場預測

第11章中東·非洲的失智症·阿茲海默症治療市場預測

市場規模與預測
市場佔有率與預測
中東·非洲:各國分析
- 南非的失智症·阿茲海默症治療市場預測
- 沙烏地阿拉伯的失智症·阿茲海默症治療市場預測
- 阿拉伯聯合大公國的失智症·阿茲海默症治療市場預測

第12章市場動態

促進因素
課題

第13章市場趨勢與發展

第14章競爭情形

Merz Pharma GmbH & Co. KGaA
Novartis AG
Pfizer, Inc.
Ono Pharmaceutical Co., Ltd.
Johnson & Johnson Services, Inc.
H. Lundbeck A/S
F. Hoffmann-La Roche Ltd.
AbbVie Inc.
Eli Lilly and Company
Corium, Inc.

第15章策略性建議

簡介目錄

Product Code: 5058

Global dementia and Alzheimer's disease treatment market is expected to grow at impressive growth during the forecast period, 2024-2028. The increasing cases of Alzheimer's and dementia coupled with growing awareness regarding the diseases are bolstering the growth of the market. Moreover, elderly population are more prone to such diseases due to growing age, which in turn, is expected to positively impact the growth of market. Also, upsurge in R&D activities associated with disease, the introduction of new and innovative technologies and drugs, and increasing government initiatives such as investments, awareness programmes are expected to bolster the growth of market over the next few years. For instance, in 2022, a new initiative by McGill University's Dementia Education Program received funding from the Public Health Agency of Canada to raise awareness of dementia and promote dementia-inclusive communities.

The global dementia and Alzheimer's disease treatment market is segmented into drug class, distribution channel, company and region. Based on drug class, the market is categorized into cholinergic/cholinesterase (ChE) inhibitors, memantine, and combination drugs. Out of these, the cholinergic/cholinesterase (ChE) inhibitor segment dominates the dementia and Alzheimer's disease market. This is accredited to fact that it is first line of treatment for AD and most widely prescribed drug for the treatment. In addition, the drug is very effective for treating mild to severe dementia, which is contributing to the increasing growth of the segment.

The memantine segment is further expected to be the fastest growing segment during the forecast period. This is ascribed to its suitability in cholinergic/cholinesterase inhibitors intolerant patients suffering from AD.

Major players operating in the global dementia and Alzheimer's disease treatment market include Merz Pharma GmbH & Co. KGaA, Novartis AG, Pfizer, Inc., Ono Pharmaceutical Co., Ltd., Johnson & Johnson Services, Inc., H. Lundbeck A/S, F. Hoffmann-La Roche Ltd., AbbVie Inc., Eli Lilly and Company, and Corium, Inc. The companies are adopting new strategies in order to stay competitive in the market. Rising competitiveness is anticipated to drive innovation in the market, thereby helping the industry to solve existing challenges and meet the needs of the market.

Objective of the Study

To analyze and estimate the market size of global dementia and Alzheimer's disease treatment market from 2018 to 2021.
To estimate and forecast the market size of global dementia and Alzheimer's disease treatment market from 2022 to 2028 and growth rate until 2028.
To classify and forecast global dementia and Alzheimer's disease treatment market based on drug class, distribution channel, company and regional distribution.
To identify dominant region or segment in the global dementia and Alzheimer's disease treatment market.
To identify drivers and challenges for global dementia and Alzheimer's disease treatment market.
To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global dementia and Alzheimer's disease treatment market.
To conduct pricing analysis for global dementia and Alzheimer's disease treatment market.
To identify and analyze the profile of leading players operating in global dementia and Alzheimer's disease treatment market.
to identify key sustainable strategies adopted by market players in global dementia and Alzheimer's disease treatment market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the hospitals and presence of all major players across the globe.

TechSci Research calculated the market size of global dementia and Alzheimer's disease treatment market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

Dementia and Alzheimer's disease treatment facilities and other stakeholders
Government bodies such as regulating authorities and policy makers
Organizations, forums and alliances related to dementia and Alzheimer's disease treatment
Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as companies, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global dementia and Alzheimer's disease treatment market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Global Dementia and Alzheimer's Disease Treatment Market, By Drug Class:

Cholinergic/ Cholinesterase Inhibitors
- Donepezil
- Galantamine
- Rivastigmine
Memantine
Combination Drugs
- Memantine
- Donepezil
- Global Dementia and Alzheimer's Disease Treatment Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Dementia and Alzheimer's Disease Treatment Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
South America
- Brazil
- Argentina
- Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global dementia and Alzheimer's disease treatment market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Clinical Trial Analysis

5.1. Ongoing Clinical Trials
5.2. Completed Clinical Trials
5.3. Terminated Clinical Trials
5.4. Breakdown of Pipeline, By Development Phase
5.5. Breakdown of Pipeline, By Status
5.6. Breakdown of Pipeline, By Study Type
5.7. Breakdown of Pipeline, By Country
5.8. Clinical Trials Heat Map

6. Global Dementia and Alzheimer's Disease Treatment Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Drug Class (Cholinergic/ Cholinesterase (ChE) Inhibitors [Donepezil, Galantamine, Rivastigmine], Memantine, Combination Drugs [Memantine & Donepezil]
- 6.2.2. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies)
- 6.2.3. By Company (2022)
- 6.2.4. By Region
6.3. Market Attractiveness Index

7. Asia-Pacific Dementia and Alzheimer's Disease Treatment Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Drug Class
- 7.2.2. By Distribution Channel
- 7.2.3. By Country
7.3. Asia-Pacific: Country Analysis
- 7.3.1. China Dementia and Alzheimer's Disease Treatment Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Drug Class
    - 7.3.1.2.2. By Distribution Channel
- 7.3.2. India Dementia and Alzheimer's Disease Treatment Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Drug Class
    - 7.3.2.2.2. By Distribution Channel
- 7.3.3. Australia Dementia and Alzheimer's Disease Treatment Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Drug Class
    - 7.3.3.2.2. By Distribution Channel
- 7.3.4. Japan Dementia and Alzheimer's Disease Treatment Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Drug Class
    - 7.3.4.2.2. By Distribution Channel
- 7.3.5. South Korea Dementia and Alzheimer's Disease Treatment Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Drug Class
    - 7.3.5.2.2. By Distribution Channel

8. Europe Dementia and Alzheimer's Disease Treatment Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Drug Class
- 8.2.2. By Distribution Channel
- 8.2.3. By Country
8.3. Europe: Country Analysis
- 8.3.1. France Dementia and Alzheimer's Disease Treatment Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Drug Class
    - 8.3.1.2.2. By Distribution Channel
- 8.3.2. Germany Dementia and Alzheimer's Disease Treatment Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Drug Class
    - 8.3.2.2.2. By Distribution Channel
- 8.3.3. United Kingdom Dementia and Alzheimer's Disease Treatment Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Drug Class
    - 8.3.3.2.2. By Distribution Channel
- 8.3.4. Italy Dementia and Alzheimer's Disease Treatment Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Drug Class
    - 8.3.4.2.2. By Distribution Channel
- 8.3.5. Spain Dementia and Alzheimer's Disease Treatment Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Drug Class
    - 8.3.5.2.2. By Distribution Channel

9. North America Dementia and Alzheimer's Disease Treatment Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Drug Class
- 9.2.2. By Distribution Channel
- 9.2.3. By Country
9.3. North America: Country Analysis
- 9.3.1. United States Dementia and Alzheimer's Disease Treatment Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Drug Class
    - 9.3.1.2.2. By Distribution Channel
- 9.3.2. Mexico Dementia and Alzheimer's Disease Treatment Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Drug Class
    - 9.3.2.2.2. By Distribution Channel
- 9.3.3. Canada Dementia and Alzheimer's Disease Treatment Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Drug Class
    - 9.3.3.2.2. By Distribution Channel

10. South America Dementia and Alzheimer's Disease Treatment Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Drug Class
- 10.2.2. By Distribution Channel
- 10.2.3. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Dementia and Alzheimer's Disease Treatment Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Drug Class
    - 10.3.1.2.2. By Distribution Channel
- 10.3.2. Argentina Dementia and Alzheimer's Disease Treatment Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Drug Class
    - 10.3.2.2.2. By Distribution Channel
- 10.3.3. Colombia Dementia and Alzheimer's Disease Treatment Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Drug Class
    - 10.3.3.2.2. By Distribution Channel

11. Middle East and Africa Dementia and Alzheimer's Disease Treatment Market Outlook

11.1. Market Size & Forecast
- 11.1.1. By Value
11.2. Market Share & Forecast
- 11.2.1. By Drug Class
- 11.2.2. By Distribution Channel
- 11.2.3. By Country
11.3. MEA: Country Analysis
- 11.3.1. South Africa Dementia and Alzheimer's Disease Treatment Market Outlook
  - 11.3.1.1. Market Size & Forecast
    - 11.3.1.1.1. By Value
  - 11.3.1.2. Market Share & Forecast
    - 11.3.1.2.1. By Drug Class
    - 11.3.1.2.2. By Distribution Channel
- 11.3.2. Saudi Arabia Dementia and Alzheimer's Disease Treatment Market Outlook
  - 11.3.2.1. Market Size & Forecast
    - 11.3.2.1.1. By Value
  - 11.3.2.2. Market Share & Forecast
    - 11.3.2.2.1. By Drug Class
    - 11.3.2.2.2. By Distribution Channel
- 11.3.3. UAE Dementia and Alzheimer's Disease Treatment Market Outlook
  - 11.3.3.1. Market Size & Forecast
    - 11.3.3.1.1. By Value
  - 11.3.3.2. Market Share & Forecast
    - 11.3.3.2.1. By Drug Class
    - 11.3.3.2.2. By Distribution Channel